From : Maia Nikoleishvili
To : Chintesh S. Dwivedi <ChinteshDwivedi@zyduscadila.com>
Subject : RE: [EXTERNAL] RE: [EXTERNAL] Request from MoH Georgia regarding procuring Remdesivir
Cc : Keyur Parekh <keyurparekh@zyduscadila.com>; Tamar Gabunia <tgabunia@moh.gov.ge>
Received On : 12.10.2020 07:06

Dear Chintesh,

Many thanks for fruitful negotiations.

We will discuss internally this proposal and get back to you soon.

With best regards,

Maia

 

 

From: Chintesh S. Dwivedi
Sent: Monday, October 12, 2020 9:02 AM
To: Maia Nikoleishvili
Cc: Keyur Parekh ; Tamar Gabunia ; Archil Dzuliashvili
Subject: RE: [EXTERNAL] RE: [EXTERNAL] Request from MoH Georgia regarding procuring Remdesivir

 

Dear Maia,

 

This is with reference to our discussion on Remdesivir 100 mg requirement of MOH-Georgia.

For 3000 Qty, we earlier proposed USD 42/Vial CIF. Based on our discussion, considering government requirement, as a special case we propose our best offer as mentioned:

 

Product - Remdesivir 100 mg  

Quantity - 3000 VIALs

Rate – USD 32 FOB or USD 34 CIP

Payment Terms – 100% Advance Payment

Delivery Schedule (Dispatch Date) – 2nd Nov-2020

 

Kindly confirm and release Purchase Order (PO), so that we can initiate supply process immediately.

 

Regards;

Chintesh

+91 8511093147

 

From: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>
Sent: 11 October 2020 14:32
To: Chintesh S. Dwivedi <ChinteshDwivedi@zyduscadila.com>
Cc: Keyur Parekh <keyurparekh@zyduscadila.com>; Tamar Gabunia <tgabunia@moh.gov.ge>; Archil Dzuliashvili <a.dzuliashvili@mfa.gov.ge>
Subject: [EXTERNAL] RE: [EXTERNAL] Request from MoH Georgia regarding procuring Remdesivir

 

Dear Mr. Dwivedi,

Many thanks for your prompt reply.

The required quantity at this point is 3000 Remdesivir 100 mg Vial.

Please, kindly inform us the price and terms & schedule of delivery for these amount as well as let us know what is the minimum amount of order that could be accepted by the company.

Thank you once again for cooperation.

Best regards,

Maia

 

From: Chintesh S. Dwivedi [mailto:ChinteshDwivedi@zyduscadila.com]
Sent: 11 October, 2020 12:17
To: Maia Nikoleishvili
Cc: Keyur Parekh
Subject: RE: [EXTERNAL] Request from MoH Georgia regarding procuring Remdesivir

 

Dear Mr Nikoleishvili,

 

Thank you for your inquiry about Remdesivir requirement of Georgia.

This is Chintesh Dwivedi from Business Development Team of Cadila Healthcare Ltd, India.

Kindly specify required quantity of Remdesivir 100mg Vial. Accordingly, we will provide our best possible pricing offer and other supply terms & schedule.

 

Thanks again for considering Cadila Healthcare Ltd and providing this opportunity to be able to serve patients in Georgia. Look forward for your inputs ASAP.

 

Regards;

Chintesh Dwivedi

+91 8511093147

 

From: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>
Sent: Saturday, October 10, 2020 22:45
To: Amrut Medhekar <amrutmedhekar@zyduscadila.com>; Ashish Trivedi <Ashish.Trivedi@zyduscadila.com>; Ganesh Nayak <ganesh.nayak@zyduscadila.com>; Kumar K Singh <kumarksingh@zyduscadila.com>
Cc: Tamar Gabunia <tgabunia@moh.gov.ge>; Archil Dzuliashvili <a.dzuliashvili@mfa.gov.ge>
Subject: [EXTERNAL] Request from MoH Georgia regarding procuring Remdesivir
Importance: High

 

 

Dear Sirs,

I would like to kindly address you from the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia regarding procuring generic form of Remdesivir manufactured by the Cadila Healthcare Limited under a license from Gilead Science Inc.

Considering current epidemiological situation, we are committed to use all existing opportunities, including engagement in the study of Remdesivir for the treatment of the patients with severe acute respiratory syndrome of COVID-19 in order to avoid fatal outcomes in the infected patients as far as possible.

Therefore, we urgently need to procurer  Remdesivir, initially sufficient for 500 eligible patients and kindly request you to provide us with the product price as well as terms and conditions of delivery as early as possible.

We rely on your support and do hope that our cooperation will be fruitful and successful.

Looking forward to receiving your feedback as soon as possible.

Sincerely yours,

 

Maia Nikoleishvili MPA

 

Head of International Relations and Protocol Division

Ministry of IDPs from the Occupied Territories, Labour, Health and Social Affairs of Georgia

Address: 144 Tsereteli ave., 0159 Tbilisi, Georgia

Tel.: +995 32 2510034 (0803)

Cell phone: +995 577272713

E-mail: mnikoleishvili@moh.gov.ge

 

Disclaimer: The information contained in this electronic message or in any trailing messages herein or in any attachments to this message is confidential, legally privileged and non-public information, intended to be conveyed only to the designated recipient(s). If you are not the intended recipient of this electronic message, please notify the sender immediately, delete this electronic message and its attachments, without reading or saving them in any manner and preserve its confidentiality. You are hereby notified that any unauthorized distribution, disclosure, copying, review, retransmission, dissemination or other use of this electronic message or the information contained in it, is strictly prohibited and may be unlawful. Before opening any attachment(s) to this electronic message, please check them for viruses and defects. Neither sender nor his/her organization accepts any liability for damage caused by any virus transmitted by this electronic message.’ If the disclaimer can't be applied, take no action.

Disclaimer: The information contained in this electronic message or in any trailing messages herein or in any attachments to this message is confidential, legally privileged and non-public information, intended to be conveyed only to the designated recipient(s). If you are not the intended recipient of this electronic message, please notify the sender immediately, delete this electronic message and its attachments, without reading or saving them in any manner and preserve its confidentiality. You are hereby notified that any unauthorized distribution, disclosure, copying, review, retransmission, dissemination or other use of this electronic message or the information contained in it, is strictly prohibited and may be unlawful. Before opening any attachment(s) to this electronic message, please check them for viruses and defects. Neither sender nor his/her organization accepts any liability for damage caused by any virus transmitted by this electronic message.’ If the disclaimer can't be applied, take no action.

Disclaimer: The information contained in this electronic message or in any trailing messages herein or in any attachments to this message is confidential, legally privileged and non-public information, intended to be conveyed only to the designated recipient(s). If you are not the intended recipient of this electronic message, please notify the sender immediately, delete this electronic message and its attachments, without reading or saving them in any manner and preserve its confidentiality. You are hereby notified that any unauthorized distribution, disclosure, copying, review, retransmission, dissemination or other use of this electronic message or the information contained in it, is strictly prohibited and may be unlawful. Before opening any attachment(s) to this electronic message, please check them for viruses and defects. Neither sender nor his/her organization accepts any liability for damage caused by any virus transmitted by this electronic message.’ If the disclaimer can't be applied, take no action.

Disclaimer: The information contained in this electronic message or in any trailing messages herein or in any attachments to this message is confidential, legally privileged and non-public information, intended to be conveyed only to the designated recipient(s). If you are not the intended recipient of this electronic message, please notify the sender immediately, delete this electronic message and its attachments, without reading or saving them in any manner and preserve its confidentiality. You are hereby notified that any unauthorized distribution, disclosure, copying, review, retransmission, dissemination or other use of this electronic message or the information contained in it, is strictly prohibited and may be unlawful. Before opening any attachment(s) to this electronic message, please check them for viruses and defects. Neither sender nor his/her organization accepts any liability for damage caused by any virus transmitted by this electronic message.’ If the disclaimer can't be applied, take no action.